|
|||
|
Multiple Sclerosis Information
Search
This Month
Favorite Links
Month Archive
|
Friday, March 27
by
All About MS
on Fri 27 Mar 2009 09:53 AM CST
Did you know multiple sclerosis (MS) affects approximately 400,000 Americans and is the leading cause of neurological disability in young adults? As all currently available treatments for MS are given through injections or infusions many patients are anxiously awaiting an oral treatment option more »
Wednesday, March 25
by
All About MS
on Wed 25 Mar 2009 08:59 AM CST
Laquinimod drug trials for RRMS more »
Sunday, March 22
by
All About MS
on Sun 22 Mar 2009 09:31 AM CST
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes, today announced an update on the continuing analysis of the company’s Phase IIb more »
|
||